Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.23.16 (
HIV-1 protease
)
2,107
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A full-length and C-terminally truncated version of human endogenous retrovirus (HERV)-K10 protease were expressed in Escherichia coli and purified to homogeneity. Both versions of the protease efficiently processed HERV-K10 Gag polyprotein substrate. HERV-K10 Gag was also cleaved by human immunodeficiency virus, type 1 (HIV-1) protease, although at different sites. To identify compounds that could inhibit protein processing dependent on the HERV-K10 protease, a series of cyclic ureas that had previously been shown to inhibit
HIV-1 protease
was tested. Several symmetric bisamides acted as very potent inhibitors of both the truncated and full-length form of HERV-K10 protease, in subnanomolar or nanomolar range, respectively. One of the cyclic ureas, SD146, can inhibit the processing of in vitro translated HERV-K10 Gag polyprotein substrate by HERV-K10 protease. In addition, in virus-like particles isolated from the teratocarcinoma cell line NCCIT, there is significant accumulation of Gag and Gag-Pol precursors upon treatment with SD146, suggesting the compound efficiently blocks
HERV-K
Gag processing in cells. This is the first report of an inhibitor able to block cell-associated processing of Gag polypeptides of an endogenous retrovirus.
...
PMID:Inhibition of human endogenous retrovirus-K10 protease in cell-free and cell-based assays. 1127 33
The human genome harbors numerous distinct families of so-called human endogenous retroviruses (HERV) which are remnants of exogenous retroviruses that entered the germ line millions of years ago. We describe here the hitherto little-characterized betaretrovirus
HERV-K
(HML-5) family (named HERVK22 in Repbase) in greater detail. Out of 139 proviruses, only a few loci represent full-length proviruses, and many lack
gag protease
and/or env gene regions. We generated a consensus sequence from multiple alignment of 62 HML-5 loci that displays open reading frames for the four major retroviral proteins. Four HML-5 long terminal repeat (LTR) subfamilies were identified that are associated with monophyletic proviral bodies, implying different evolution of HML-5 LTRs and genes. Sequence analysis indicated that the proviruses formed approximately 55 million years ago. Accordingly, HML-5 proviral sequences were detected in Old World and New World primates but not in prosimians. No recent activity is associated with this HERV family. We also conclude that the HML-5 consensus sequence primer binding site is identical to methionine tRNA. Therefore, the family should be designated HERV-M. Our study provides important insights into the structure and evolution of the oldest betaretrovirus in the primate genome known to date.
...
PMID:Human endogenous retrovirus family HERV-K(HML-5): status, evolution, and reconstruction of an ancient betaretrovirus in the human genome. 1528 Apr 87
Human endogenous retroviruses (HERVs), which are remnants of ancestral retroviruses integrated into the human genome, are defective in viral replication. Because activation of
HERV-K
and coexpression of this virus with HIV-1 have been observed during HIV-1 infection, it is conceivable that
HERV-K
could affect HIV-1 replication, either by competition or by cooperation, in cells expressing both viruses. In this study, we found that the release efficiency of HIV-1 Gag was 3-fold reduced upon overexpression of
HERV-K
(CON) Gag. In addition, we observed that in cells expressing Gag proteins of both viruses,
HERV-K
(CON) Gag colocalized with HIV-1 Gag at the plasma membrane. Furthermore,
HERV-K
(CON) Gag was found to coassemble with HIV-1 Gag, as demonstrated by (i) processing of
HERV-K
(CON) Gag by
HIV-1 protease
in virions, (ii) coimmunoprecipitation of virion-associated
HERV-K
(CON) Gag with HIV-1 Gag, and (iii) rescue of a late-domain-defective
HERV-K
(CON) Gag by wild-type (WT) HIV-1 Gag. Myristylation-deficient
HERV-K
(CON) Gag localized to nuclei, suggesting cryptic nuclear trafficking of
HERV-K
Gag. Notably, unlike WT
HERV-K
(CON) Gag, HIV-1 Gag failed to rescue myristylation-deficient
HERV-K
(CON) Gag to the plasma membrane. Efficient colocalization and coassembly of HIV-1 Gag and
HERV-K
Gag also required nucleocapsid (NC). These results provide evidence that HIV-1 Gag heteromultimerizes with
HERV-K
Gag at the plasma membrane, presumably through NC-RNA interaction. Intriguingly,
HERV-K
Gag overexpression reduced not only HIV-1 release efficiency but also HIV-1 infectivity in a myristylation- and NC-dependent manner. Altogether, these results indicate that Gag proteins of endogenous retroviruses can coassemble with HIV-1 Gag and modulate the late phase of HIV-1 replication.
...
PMID:Human endogenous retrovirus K Gag coassembles with HIV-1 Gag and reduces the release efficiency and infectivity of HIV-1. 2285 97